Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24098416 | 0.98 | CYP1A2 (0.37) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979346 | 0.90 | CYP1A2 (0.35) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979293 | 0.90 | CYP1A2 (0.35) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979206 | 0.90 | CYP1A2 (0.35) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979209 | 0.90 | CYP1A2 (0.35) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979967 | 0.88 | CYP1A2 (0.33) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979795 | 0.85 | GAA (0.32) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979845 | 0.85 | CYP1A2 (0.33) | CYP1A2CYP2C19CYP2C9RECQLTSHR | |
| SCHEMBL25979963 | 0.83 | KDM4E (0.32) | CYP1A2CYP2C19TSHRGAAKDM4E | |
| SCHEMBL25979747 | 0.83 | GAA (0.33) | CYP1A2CYP2C19CYP2C9RECQLTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | NONO, EPHA4, EPHA6 | CYP1A2 4104/4885CYP2C19 2101/4885CYP2C9 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.